Claims for Patent: 11,542,278
Summary for Patent: 11,542,278
| Title: | Heteroaromatic macrocyclic ether chemotherapeutic agents |
| Abstract: | Disclosed are heterocyclic heteroaromatic macrocyclic ether compounds of Formula (I): pharmaceutically acceptable salts of the compounds and pharmaceutical compositions thereof. The disclosure further relates to methods of treating or preventing cancer using the heterocyclic heteroaromatic macrocyclic ether compounds, pharmaceutically acceptable salts of the compounds and pharmaceutical compositions thereof. |
| Inventor(s): | Joshua Courtney Horan, Xinxing Tang, Scot Richard Mente, Henry Efrem Pelish, Matthew D. Shair, Anupong Tangpeerachaikul |
| Assignee: | Pharmaresources Co Ltd , Nuvalent Inc |
| Application Number: | US17/514,877 |
| Patent Claims: |
1. A compound of Formula (I): or a pharmaceutically acceptable salt, enantiomer, or tautomer thereof, wherein: Q is CH; Z is CR5; X is: wherein: * indicates the point of attachment of X to the —CH2— group bonded to Y; Y is: wherein: * indicates the point of attachment of Y to the —CH2— group bonded to X; R1 is H, CH3, or CH2OH; each R2 is independently H, halo, C1-4 alkyl, C1-4 haloalkyl, CH2—C3-4 cycloalkyl, OC1-4 alkyl, C3-6 cycloalkyl, or C3-6 heterocycloalkyl; R3 is H, halo, CN, C1-4 alkyl, C1-4 haloalkyl, or OC1-4 alkyl; R4 is H or F; and R5 is H or F. 2. A compound of Formula (I-B): or a pharmaceutically acceptable salt thereof, wherein: Q is CH; Z is CR5; X is: wherein: * indicates the point of attachment of X to the —CH2— group bonded to Y; Y is: wherein: * indicates the point of attachment of Y to the —CH2— group bonded to X; R1 is H, CH3, or CH2OH; each R2 is independently H, halo, C1-4 alkyl, C1-4 haloalkyl, CH2—C3-4 cycloalkyl, OC1-4 alkyl, C3-6 cycloalkyl, or C3-6 heterocycloalkyl; R3 is H, halo, CN, C1-4 alkyl, C1-4 haloalkyl, or OC1-4 alkyl; R4 is H or F; and R5 is H or F. 3. The compound of claim 2, or a pharmaceutically acceptable salt thereof, wherein each R2 is independently H, Cl, CH3, CH2CH3, CH2CH(CH3)2, CHF2, CF3, CH2CH2F, CH2CHF2, CH2-cyclopropyl, OCH3, cyclopropyl, cyclobutyl, or oxetanyl. 4. The compound of claim 2, or a pharmaceutically acceptable salt thereof, wherein R3 is H, F, Cl, CN, CH3, or H2CH3. 5. The compound of claim 4, or a pharmaceutically acceptable salt thereof, wherein R4 is F. 6. The compound of claim 5, or a pharmaceutically acceptable salt thereof, wherein R5 is H. 7. The compound of claim 2, wherein the compound is: or a pharmaceutically acceptable salt thereof. 8. The compound of claim 2, wherein the compound is: or a pharmaceutically acceptable salt thereof. 9. The compound of claim 2, wherein the compound is: or a pharmaceutically acceptable salt thereof. 10. The compound of claim 2, wherein the compound is: or a pharmaceutically acceptable salt thereof. 11. The compound of claim 2, wherein the compound is: or a pharmaceutically acceptable salt thereof. 12. The compound of claim 2, wherein the compound is: or a pharmaceutically acceptable salt thereof. 13. The compound of claim 2, wherein the compound is: or a pharmaceutically acceptable salt thereof. 14. The compound of claim 2, wherein the compound is: or a pharmaceutically acceptable salt thereof. 15. The compound of claim 2, wherein the compound is: or a pharmaceutically acceptable salt thereof. 16. The compound of claim 2, wherein the compound is: or a pharmaceutically acceptable salt thereof. 17. The compound of claim 2, wherein the compound is: or a pharmaceutically acceptable salt thereof. 18. The compound of claim 2, wherein the compound is: or a pharmaceutically acceptable salt thereof. 19. A pharmaceutical composition comprising (i) a pharmaceutically acceptable carrier or excipient, and (ii) the compound of claim 7, or a pharmaceutically acceptable salt thereof. 20. A pharmaceutical composition comprising (i) a pharmaceutically acceptable carrier or excipient, and (ii) the compound of claim 8, or a pharmaceutically acceptable salt thereof. 21. A pharmaceutical composition comprising (i) a pharmaceutically acceptable carrier or excipient, and (ii) the compound of claim 9, or a pharmaceutically acceptable salt thereof. 22. A pharmaceutical composition comprising (i) a pharmaceutically acceptable carrier or excipient, and (ii) the compound of claim 10, or a pharmaceutically acceptable salt thereof. 23. A pharmaceutical composition comprising (i) a pharmaceutically acceptable carrier or excipient, and (ii) the compound of claim 11, or a pharmaceutically acceptable salt thereof. 24. A pharmaceutical composition comprising (i) a pharmaceutically acceptable carrier or excipient, and (ii) the compound of claim 12, or a pharmaceutically acceptable salt thereof. 25. A pharmaceutical composition comprising (i) a pharmaceutically acceptable carrier or excipient, and (ii) the compound of claim 13, or a pharmaceutically acceptable salt thereof. 26. A pharmaceutical composition comprising (i) a pharmaceutically acceptable carrier or excipient, and (ii) the compound of claim 14, or a pharmaceutically acceptable salt thereof. 27. A pharmaceutical composition comprising (i) a pharmaceutically acceptable carrier or excipient, and (ii) the compound of claim 15, or a pharmaceutically acceptable salt thereof. 28. A pharmaceutical composition comprising (i) a pharmaceutically acceptable carrier or excipient, and (ii) the compound of claim 16, or a pharmaceutically acceptable salt thereof. 29. A pharmaceutical composition comprising (i) a pharmaceutically acceptable carrier or excipient, and (ii) the compound of claim 17, or a pharmaceutically acceptable salt thereof. 30. A pharmaceutical composition comprising (i) a pharmaceutically acceptable carrier or excipient, and (ii) the compound of claim 18, or a pharmaceutically acceptable salt thereof. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
